Monday, September 26, 2022
Home Tags Cemiplimab

Tag: cemiplimab

FDA approves Regeneron, Sanofi skin cancer immuno-oncology drug

The drug is the first FDA-approved treatment for patients with advanced forms of a skin cancer known as cutaneous squamous cell carcinoma. 

European agency to review Regeneron-Sanofi drug applications

The European agency will also review the marketing authorization application for cemiplimab, which is used to treat patients with metastatic cutaneous squamous cell carcinoma.

Regeneron collaborates with Dutch company on combined cancer treatment

Regeneron in the agreement has an option to exclusively license an ISA Pharmaceuticals drug that targets cancers linked to a human papilloma virus.